Surmodics | SRDX - Loan Capital


Surmodics reported $29.55M in Loan Capital for its fiscal quarter ending in September of 2024.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Align Technology USD 0 0 Dec/2024
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Artivion USD 214.87M 669K Sep/2025
Baxter International USD 9.47B 726M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
EDAP TMS EUR 1.01M 13K Sep/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Haemonetics USD 919.99M 406K Dec/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
J&J USD 39.44B 30M Dec/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Option Care Health USD 1.15B 1M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.55M 30K Sep/2024
Trinity Biotech USD 114.86M 4.81M Sep/2025